Aarti Drugs Limited Share Price and Company Fundamentals



Price
₹402.95
Change
0.200 (0.050%)
52 week
378.0 - 749.75

Last traded: Today at 8:54 AM

Aarti Drugs Limited, through its subsidiaries, engages in the pharmaceuticals business in India and internationally. The company offers active pharmaceutical ingredients in various therapeutic categories, including anti-inflammatory, cardioprotectants, antidiarrhoeals, antifungals, antiarthritis/osteoporosis, antibiotics, antidiabetics, Alzheimer's treatment, sedatives, vitamins, and alcoholism treatment; and pharmaceutical intermediate products comprising tinidazole, celecoxib, ciprofloxacin, clopidogrel, diclofenac, ketoconazole, nimesulide, and raloxifene. It also offers specialty chemical products, such as benzene sulphonamide, benzene sulphonic acid, benzene sulphonic acid methyl ester, benzene sulphonyl chloride, cipro Q acid, levofloxacin Q acid, methyl nicotinate, N-methyl methane sulphonamide, diphenyl sulphone, norofloxacin Q acid, ofloxacin Q acid, ortho para toluene sulphonamide, ortho/para toluene sulphonic acid methyl ester, para chloro benzene sulphonamide, para chloro benzene sulphonyl chloride, para toluene sulphonamide, para toluene sulphonic acid methyl ester, para toluene sulphonyl chloride, and sodium benezene sulfinate, as well as para toluene sulphonyl hydrazide, sodium salt, benzyl nicotinate, bisphenol – C, bisphenol – C(chloride), ethyl nicotinate, ethyl para toluene sulphonate, and N-methyl imidazole. In addition, the company's products under development comprise Acamprosate for alcoholism; Dabigatran for use as an anticoagulant; Sevelamer for antihyperphosphatemia; Colsevelam for anti-cholestrol treatment; Drondarone and Olmesartan for the treatment of cardiovascular diseases; Valasartan for use as cardiprotectant; and Sitagliptin for use as an antidiabetic. Additionally, it offers contract manufacturing services. The company was incorporated in 1984 and is headquartered in Mumbai, India.

Key Metrics

PE ratio

18.33

PB ratio

3.63

Dividend yield

0.25%

Beta

1.17

Market cap

-

Enterprise value

-

Company profile

Industry / SectorDrug Manufacturers—Specialty & Generic / Healthcare
Websitehttps://www.aartidrugs.co.in
Mailing addressMahendra Industrial Estate Ground Floor Road No. 29, Plot No. 109D Sion (East) Mumbai 400 022 India
Phone / Fax91 22 2401 9025 / 91 22 2407 3462

Dividends

Dividend yield

0.25%

Dividend amount

₹1.00

Payout ratio

4.52%

Aarti Drugs Limited paid ₹1.00 dividend and the ex-dividend date was 09 Feb 2022.The dividend payout ratio is 4.52%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.AARTIDRUGS dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.

AARTIDRUGS's forward dividend amount is ₹1 and the forward dividend yield is 0.25%. A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.

Company Executives

As of Jul 2022, following are the company executives and directors listed on Aarti Drugs Limited.

NameTitleAgeTotal Pay
Mr. Prakash Moreshwar PatilChairman, MD, CEO & Head of BR7434.64M
Mr. Harshit Manila SavlaJoint MD & Exec. Director5933.59M
Mr. Harit Pragji ShahWhole-Time Director5833.59M
Mr. Uday Moreshwar PatilWhole-Time Director581.49M
Mr. Rashesh Chandrakant GogriMD & Exec. Director4733.59M
Mr. Adhish Prakash PatilCFO & Director38
Mr. Dhanaji L. KakadeVP of Technical
Mr. Rushikesh DeoleCompany Sec. & Compliance Officer
Mr. Vishwa Harshit SavlaDirector of Pinnacle of Life Sciences

Profitability and management effectiveness

Profit margin

8.24%

Operating margin

11.23%

Return on assets

8.79%

Return on equity

21.03%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Aarti Drugs Limited is and its enterprise value is .

The AARTIDRUGS's stocks Beta value is 1.17 making it 17% more volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Aarti Drugs Limited (NSE:AARTIDRUGS) Frequently Asked Questions

1. What is Aarti Drugs Limited's Stock Symbol?

Aarti Drugs Limited trades on NSE under the ticker symbol "AARTIDRUGS".

2. What is Aarti Drugs Limited's stock price today?

One share of AARTIDRUGS stock can currently be purchased for approximately ₹402.95.

3. How can I contact Aarti Drugs Limited?

Aarti Drugs Limited's mailing address is Mahendra Industrial Estate Ground Floor Road No. 29, Plot No. 109D Sion (East) Mumbai 400 022 India. The company can be reached via phone at 91 22 2401 9025.

4. What is Aarti Drugs Limited's official website?

The official website of Aarti Drugs Limited is https://www.aartidrugs.co.in.